Check4
IdentifySensors Biologics has developed a groundbreaking new technology that uses electronic nanosensors to detect the presence of COVID and other pathogens in saliva. This technology exists nowhere else on the market today, and Acclaim has driven the entire marketing and public relations campaign that has helped the company raise millions of dollars in investments and drive the product to commercialization.
Social Media Campaigns
Acclaim worked with IdentifySensors Biologics to develop extensive social media campaigns that drove millions of dollars in investments. The process began with a crowdfunding mechanism in cooperation with the SEC, while the investment relations team turned entry level investors to major investors .
Explaining new technology as nebulous as nanosensors that detect viruses is no small task. So Acclaim used a hybrid of traditional interviews with digital animation to tell the story.
Website and Sales Collateral
Acclaim worked with IdentifySensor’s senior management to design, write and launch four separate websites, each serving distinctly different purposes. The company’s primary social media landing page saw more than 36,000 hits in its first month.
To learn more, email info@acclaimllc.com or call 844-375-2220.